Last $28.69 USD
Change Today +0.24 / 0.84%
Volume 1.5M
NPSP On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 4:30 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rachel R. Selisker CPA

Director and Chairman of Audit Committee, NPS Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 3 different organizations across 5 different industries.

See Board Relationships
58$194,997

Background*

Ms. Rachel R. Selisker, CPA, serves as a Director of Trivirix International Inc. and PeerMed Media Inc. Ms. Selisker has been a Director of NPS Pharmaceuticals, Inc. since January 2005 and Labopharm Inc. since November 2008. She served as Executive Vice President and Chief Financial Officer of ZeeCRO Inc. (formerly Aaipharma Inc.) since March 13, 2006 and has over 25 years of diverse business and financial experience. Ms. Selisker Co-Founded Thompson Clive & Partners ...

Read Full Background

Corporate Headquarters*

550 Hills Drive
Bedminster, New Jersey 07921

United States

Phone: 908-450-5300
Fax: 908-450-5351

Board Members Memberships*

Director
Director
Director
2005-Present
Director and Chairman of Audit Committee
2008-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

Unknown/Other Education
Wake Technical Community College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$70,000
Total Calculated Compensation$194,997
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPSP:US $28.69 USD +0.24

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NPS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.